Danusertib

DB11778InvestigationalSmall molecule

Danusertib has been used in trials studying the treatment of Leukemia.

Chemical structure of Danusertib
Formula / weight
C26H30N6O3 · 474.565 g/mol (avg)

Resolves to

Compound
UNIIM3X659D0FYCAS827318-97-8ChEMBLCHEMBL402548ChEBI94490PubChem11442891
Structure
InChIKeyXKFTZKGMDDZMJI-HSZRJFAPSA-NSMILESCO[C@@H](C(=O)N1CC2=C(C1)C(NC(=O)C1=CC=C(C=C1)N1CCN(C)CC1)=NN2)C1=CC=CC=C1
Targets
O14965AURKAQ96GD4AURKBQ9UQB9AURKC

What you can answer from here — as of January 29, 2025

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
9+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Danusertib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In